Effect of cell culture conditions on the anticytomegalovirus activity of maribavir
- PMID: 16801445
- PMCID: PMC1489798
- DOI: 10.1128/AAC.00207-06
Effect of cell culture conditions on the anticytomegalovirus activity of maribavir
Abstract
The cytomegalovirus UL97 kinase inhibitor maribavir suppressed viral growth more effectively in lung fibroblasts than in skin fibroblasts, and some cellular kinase inhibitors enhanced its antiviral activity. These effects influence the phenotypic assay of drug susceptibility and suggest the possibility of therapeutically useful combinations of maribavir and cellular kinase inhibitors.
Figures


Similar articles
-
Cytomegalovirus UL97 kinase mutations that confer maribavir resistance.J Infect Dis. 2007 Jul 1;196(1):91-4. doi: 10.1086/518514. Epub 2007 May 17. J Infect Dis. 2007. PMID: 17538888
-
Maribavir antagonizes the antiviral action of ganciclovir on human cytomegalovirus.Antimicrob Agents Chemother. 2006 Oct;50(10):3470-2. doi: 10.1128/AAC.00577-06. Antimicrob Agents Chemother. 2006. PMID: 17005835 Free PMC article.
-
Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavir.J Virol. 2004 Jul;78(13):7124-30. doi: 10.1128/JVI.78.13.7124-7130.2004. J Virol. 2004. PMID: 15194788 Free PMC article.
-
Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir.Rev Med Virol. 2008 Jul-Aug;18(4):233-46. doi: 10.1002/rmv.574. Rev Med Virol. 2008. PMID: 18383425 Review.
-
Successful oral treatment of Ganciclovir resistant cytomegalovirus with Maribavir in the context of primary immunodeficiency: First case report and review.J Clin Virol. 2017 Feb;87:12-16. doi: 10.1016/j.jcv.2016.12.006. Epub 2016 Dec 12. J Clin Virol. 2017. PMID: 27987421 Review. No abstract available.
Cited by
-
The Cytomegalovirus Protein Kinase pUL97:Host Interactions, Regulatory Mechanisms and Antiviral Drug Targeting.Microorganisms. 2020 Apr 4;8(4):515. doi: 10.3390/microorganisms8040515. Microorganisms. 2020. PMID: 32260430 Free PMC article. Review.
-
Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance.Antiviral Res. 2020 Apr;176:104711. doi: 10.1016/j.antiviral.2020.104711. Epub 2020 Jan 12. Antiviral Res. 2020. PMID: 31940472 Free PMC article. Review.
-
Inhibition of cellular STAT3 synergizes with the cytomegalovirus kinase inhibitor maribavir to disrupt infection.Antiviral Res. 2013 Nov;100(2):321-7. doi: 10.1016/j.antiviral.2013.09.011. Epub 2013 Sep 23. Antiviral Res. 2013. PMID: 24070820 Free PMC article.
-
Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant.J Virol. 2008 Jan;82(1):246-53. doi: 10.1128/JVI.01787-07. Epub 2007 Oct 17. J Virol. 2008. PMID: 17942550 Free PMC article.
-
In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246.Antimicrob Agents Chemother. 2010 Mar;54(3):1290-7. doi: 10.1128/AAC.01596-09. Epub 2010 Jan 4. Antimicrob Agents Chemother. 2010. PMID: 20047911 Free PMC article.
References
-
- Biron, K. K., R. J. Harvey, S. C. Chamberlain, S. S. Good, A. A. Smith III, M. G. Davis, C. L. Talarico, W. H. Miller, R. Ferris, R. E. Dornsife, S. C. Stanat, J. C. Drach, L. B. Townsend, and G. W. Koszalka. 2002. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole l-riboside with a unique mode of action. Antimicrob. Agents Chemother. 46:2365-2372. - PMC - PubMed
-
- Bresnahan, W. A., I. Boldogh, P. Chi, E. A. Thompson, and T. Albrecht. 1997. Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology 231:239-247. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources